Status:
COMPLETED
Defining the Serum Ferritin Concentration in Kenyan Women at Which the Body Senses Iron Depletion and Begins to Upregulate Iron Absorption
Lead Sponsor:
Swiss Federal Institute of Technology
Collaborating Sponsors:
Jomo Kenyatta University of Agriculture and Technology
Conditions:
Iron-deficiency
Ferritin Threshold
Eligibility:
FEMALE
18-28 years
Phase:
NA
Brief Summary
The serum or plasma ferritin concentration (referred to hereafter as ferritin) is the most widely used indicator to detect iron deficiency and a low ferritin indicates depleted iron stores. However, t...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Age 18-28 y, not pregnant or lactating
- Body weight \<75 kg
- body mass index (BMI) between 17 and 25 kg/m2
- No acute illness/infection (self-reported)
- No metabolic or gastrointestinal disorders (self-reported)
- No use of medications affecting iron absorption or metabolism during the study
- No intake of mineral/vitamin supplements 2 weeks prior to the first study visit and during the study
Exclusion
Key Trial Info
Start Date :
February 18 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2023
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT05266703
Start Date
February 18 2022
End Date
June 30 2023
Last Update
January 25 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Msambweni County Referral Hospital
Msambweni, Kenya